Bioresearch Monitonoring Information System (BMIS)

Metadata Updated: November 10, 2020

This contains information that identifies clinical investigators, contract research organizations, and institutional review boards involved in the conduct of Investigational New Drug (IND) studies with human investigational drugs and therapeutic biologics.

Access & Use Information

Public: This dataset is intended for public access and use. License: No license information was provided. If this work was prepared by an officer or employee of the United States government as part of that person's official duties it is considered a U.S. Government Work.

Downloads & Resources

Dates

Metadata Created Date November 10, 2020
Metadata Updated Date November 10, 2020

Metadata Source

Harvested from Healthdata.gov

Additional Metadata

Resource Type Dataset
Metadata Created Date November 10, 2020
Metadata Updated Date November 10, 2020
Publisher U.S. Food and Drug Administration
Unique Identifier Unknown
Maintainer
Identifier 8d346d8d-33c7-47f8-890d-a4ced16e45dd
Data First Published 2013-08-29
Data Last Modified 2013-08-29
Public Access Level public
Bureau Code 009:10
Metadata Context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
Metadata Catalog ID https://healthdata.gov/data.json
Schema Version https://project-open-data.cio.gov/v1.1/schema
Catalog Describedby https://project-open-data.cio.gov/v1.1/schema/catalog.json
Homepage URL http://www.fda.gov/Drugs/InformationOnDrugs/ucm135162.htm
Program Code 009:002
Source Datajson Identifier True
Source Hash 49a3d92fc980ffae646f5db354973ade4c06126b
Source Schema Version 1.1

Didn't find what you're looking for? Suggest a dataset here.